The Burden of Dementia Spectrum Disorders and Associated Comorbid and Demographic Features<br>Office- and Bedside-based Screening for Cognitive Impairment and the Dementias:Which Tools to Use, Interpreting the Results, and What Are the Next Steps?<br>Formal Neuropsychological Testing: Test Batteries, Interpretation, and Added Value in Practice<br>Brain Networks, Clinical Manifestations, and Neuroimaging of Cognitive Disorders:The Role of Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET), and Other Advanced Neuroimaging Tests<br>Blood and Cerebrospinal Fluid Biomarkers in Vascular Dementia and Alzheimer’s Disease: A Brief Review<br>What Are the Key Diagnostic Cognitive Impairment and Dementia Subtypes and How to Integrate all of the Diagnostic Data to Establish a Diagnosis?<br>Neuropathology of the Common Forms of Dementia<br>Vascular and Nonvascular Mechanisms of Cognitive Impairment and Dementia<br>The Role of Vascular Risk Factors in Cognitive Impairment and Dementia and Prospects for Prevention<br>Treatment of Vascular and Neurodegenerative Forms of Cognitive Impairment and Dementias<br>Brain Reserve, Resilience, and Cognitive Stimulation Across the Lifespan: How Do These Factors Influence Risk of Cognitive Impairment and the Dementias?<br>Diagnostic and Management Strategies for Common Neurobehavioral and Psychiatric Disturbances Among Patients with Cognitive Impairment and the Dementias<br>Harmonizing Ethno-Regionally Diverse Datasets to Advance the Global Epidemiology of Dementia